Ohio medical marijuana companies spend thousands on real estate while awaiting licenses, Missouri MMJ businesses eye ballot measures that would prove most business-friendly, and Oregon’s top federal prosecutor calls out the state’s excess cannabis output.
John Poss is a self-described rough-water sailor who has made a career of righting the ship for sinking companies.
With three decades of experience consulting for companies undergoing major upheavals, he decided three years ago to dive into the cannabis industry.
Since then, as CEO of Las Vegas-based cannabis company GB Sciences, Poss has partnered with universities in the United States and abroad.
Ohio medical marijuana dispensary applicants will have to wait until June, at the earliest, to find out if they will be licensed, even though applications have been scored.
Pennsylvania approves eight universities to conduct medical marijuana research, a company spurned for a Louisiana license sues the state, and Ohio awards an additional MMJ permit.
Here’s a closer look at some notable developments in the cannabis industry over the past week.
Pennsylvania on Monday unveiled eight universities that will be allowed to research medical marijuana, a potential boon for an industry where cannabis study is extremely limited.
